Brain cancer relapse detection is a critical area of research aimed at improving outcomes for pediatric cancer patients.A recent study conducted by Harvard researchers has unveiled the potential of artificial intelligence (AI) to predict relapse risks in children with brain tumors, specifically gliomas.